Goldline Pharmaceutical IPO Final Subscription Status
Final subscription data from BSE & NSE with category-wise breakdowns
🔥 Heating up
📈 GMP Today
🎟️ Allotment Status
📄 Full IPO Details
Listed at BSE · Registrar: Bigshare Services Pvt. Ltd.
Price: ₹41 - ₹43
Lot: 3000
Min: ₹1,29,000
Period: 12 May - 14 May
Subscribed
840.57x
Total Demand
₹6,614 Cr
Applications
—
Build by Day
22.35x
→
100.21x
→
840.57x
Subscription (Shares)
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 5,40,000 | 9,73,17,000 | 180.22 |
| NII | 3,90,000 | 64,83,15,000 | 1,662.35 |
| bNII (>10 Lakh) | 2,60,000 | 43,22,10,000 | 1,662.35 |
| sNII (2-10 Lakh) | 1,30,000 | 21,61,05,000 | 1,662.35 |
| Retail | 9,00,000 | 79,26,12,000 | 880.68 |
| TOTAL | 18,30,000 | 1,53,82,44,000 | 840.57 |
Application Breakup
| Category | Reserved | Applications | Times |
|---|---|---|---|
| NII | 43 | 1,08,052 | 2,512.84 |
| bNII (>10 Lakh) | 29 | 18,009 | 621.00 |
| sNII (2-10 Lakh) | 14 | 36,018 | 2,572.71 |
| Retail | 300 | 2,64,204 | 880.68 |
| TOTAL | 386 | 4,26,283 | 1,104.36 |
Subscription (Crores)
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIB | 2.32 | 418.46 | 180.22 |
| NII | 1.68 | 2,787.75 | 1,662.35 |
| bNII (>10 Lakh) | 1.12 | 1,858.50 | 1,662.35 |
| sNII (2-10 Lakh) | 0.56 | 929.25 | 1,662.35 |
| Retail | 3.87 | 3,408.23 | 880.68 |
| TOTAL | 7.87 | 6,614.45 | 840.57 |
Day-wise Subscription
How demand built up across the bidding days — subscription at the end of each day.
| Day | QIB | NII | bNII | sNII | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 12 May | 1.31x | 24.46x | 24.46x | 24.46x | 34.07x | 22.35x |
| Day 2 13 May | 1.31x | 146.48x | 146.48x | 146.48x | 139.51x | 100.21x |
| Day 3 14 May | 180.22x | 1662.35x | 1662.35x | 1662.35x | 880.68x | 840.57x |
Estimated Allotment Chance
Retail
0.13%
(880.68x subscribed)
Low chance
S-HNI (2-10L)
0.06%
(1,662.35x subscribed)
Low chance
B-HNI (>10L)
0.24%
(1,662.35x subscribed)
Low chance
If 100 retail investors apply, approximately 1 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results.
Actual allotment depends on the number of applications received and SEBI's allotment rules —
draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE.
Please verify with official exchange websites before making any investment decisions.
This information is for educational purposes only and should not be construed as investment advice.
Goldline Pharmaceutical IPO Subscription — Detailed Analysis
Where Goldline Pharmaceutical Subscription Finished
Goldline Pharmaceutical IPO was subscribed 840.57 times overall by the close of bidding — a heavily oversubscribed level that signals strong investor demand.
Goldline Pharmaceutical IPO Subscription — FAQs
Goldline Pharmaceutical IPO was subscribed 840.57 times overall by the close of bidding.
Goldline Pharmaceutical IPO was open for subscription from May 12, 2026 to May 14, 2026.
The price band for Goldline Pharmaceutical IPO is ₹41 - ₹43 per share.
New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.
Explore More
Quick links to all IPO sections
Open IPO
Live now
Best IPO Today
Data scores
Upcoming IPO
Coming soon
IPO Calendar
Dates & schedule
Closed IPO
Allotment pending
Listed IPO
Listing gains
IPO GMP
Grey market premium
Subscription
Live bidding data
Allotment
Check status
Allotment Chances
Your odds
SME IPO
Small & medium
Mainboard IPO
Large cap
Performance
Listing returns
Learn
IPO guides